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Abstract
Dairy products are included in dietary guidelinesworldwide, asmilk, yoghurt, and cheese are good sources of calcium and protein, vital
nutrients for bones and muscle mass maintenance. Bone growth and mineralization occur during infancy and childhood, peak bone
mass being attained after early adulthood. A low peak bonemass has consequences later in life, including increased risk of osteoporosis
and fractures. Currently, more than 200 million people worldwide suffer from osteoporosis, with approximately 9 million fractures
yearly. This poses a tremendous economic burden on health care. Between 5% and 10% of the elderly suffer from sarcopenia, the loss
of muscle mass and strength, further increasing the risk of fractures due to falls. Evidence from interventional and observational studies
support that fermented dairy products in particular exert beneficial effects on bone growth andmineralization, attenuation of bone loss,
and reduce fracture risk. The effect cannot be explained by single nutrients in dairy, which suggests that a combined or matrix effect
may be responsible similar to the matrix effects of foods on cardiometabolic health. Recently, several plant-based beverages and
products have become available and marketed as substitutes for dairy products, even though their nutrient content differs substantially
from dairy. Some of these products have been fortified, in efforts to mimic the nutritional profile of milk, but it is unknownwhether the
additives have the same bioavailability and beneficial effect as dairy. We conclude that the dairy matrix exerts an effect on bone and
muscle health that is more than the sum of its nutrients, and we suggest that whole foods, not only single nutrients, need to be assessed
in future observational and intervention studies of health outcomes. Furthermore, the importance of the matrix effect on health
outcomes argues in favor of making future dietary guidelines food based.
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Introduction
Dietary recommendations have historically focused on single
nutrients, with levels aimed at ensuring intakes sufficient to
meet bodily requirements in the different phases of life: infancy,
childhood, adolescence, adulthood, and old age. Additionally,
specific recommendations have been made for pregnant and
lactating women, and for ill individuals, circumstances where
requirements may be increased. In most cases, recommenda-
tions describe age- and gender-specific intakes sufficient to
meet requirements in 97–98% of the given population, and an
upper level, of which the intake should remain below. Often,
determination of a recommended level is based on a combina-
tion of evidence from randomized controlled trials (RCTs), ob-
servational and mechanistic studies, and on meta-analyses.
The recommended intakes of nutrients are given in measures
not easily understood by the public, e.g., protein is given in grams
per kilogram of body weight and sometimes also as grams per
day, percentage of total energy intake, or even as percentage of
food energy intake and calcium in milligrams per day [1, 2].
Furthermore, people consume foods not nutrients, and translation
from individual nutrients to foods has proven problematic for
both health professionals as well as the general public [3].
In observational studies, dietary intakes are often assessed
by questionnaires with predefined categories, and different
foods are generally grouped to match the focus of the given
investigation. Studies assessing the association between satu-
rated fatty acid (SFA) intake and risk or incidence of mortality
from coronary heart disease (CHD) are inconsistent, yet the
WHO draft guidelines recommend limiting intake of saturated
fat to 10% or less of total energy intake [4]. A recent review of
the evidence from both interventional and observational stud-
ies concluded that the health effects of SFA vary greatly de-
pending on the specific fatty acid, that some foods containing
SFA are often sources of essential nutrients, and that RCTs
have found foods such as cheese and dark chocolate to have
beneficial effects on cardiovascular biomarkers [5].
The importance of sufficient dietary intake and absorption
of protein and vitamin D for optimal muscle strength is well
proven, and recently a gut–muscle axis, a cross-talk between
the gut microbiota and muscle, has been found to be important
for muscular size, strength, and function [6]. Similarly, a link
between gut microbiota and bone exists, influencing bone
strength and mineral density beyond the effect of calcium,
phosphorus, and protein intake (see Rizzoli et al. 2019 for
review [7]). The consumption of fermented dairy products
containing pre- and probiotics may possibly induce changes
in hormones and cytokines, e.g., reduce parathyroid hormones
and tumor necrosis factor-alpha (TNF-α), causing a reduction
in bone resorption and an increase in insulin-like growth
factor-I (IGF-I), thus leading to increased bone formation
and affecting the absorption of calcium [8].
The above highlights the necessity of viewing and investigat-
ing dairy as awhole food exertingmatrix effects than focusing on
single nutrients or the sum of single nutrients. This will allow for
more practical and food-based nutritional recommendations.
Aim and methods
The present paper is based on the presentations, discussions,
and conclusions of an expert workshop on the dairy matrix
and musculoskeletal health held in June 2019, completing and
extending a previously published expert workshop report on
dairy matrix and cardiovascular disease (CVD) held in
September 2016. The conclusion of the latter was that dairy
foods can have different and more beneficial effects on bone
health than would be expected solely on the basis of the sum
of the effects of the individual nutrients, and that overall com-
position and structure of foods needs to be considered, i.e., the
food matrix effects. Gaps in current knowledge that warrant
further exploration were identified. Aspects of protein and
muscle metabolism were also considered, but there is a need
for a more in-depth appraisal. As bone and muscle health (and
the related disease states of osteoporosis and sarcopenia) are
intrinsically linked, it was proposed that a subsequent work-
shop should address the wider aspects of musculoskeletal
health for a more comprehensive outcome.
Therefore, the aims of this 2019 workshop were to explore
current knowledge on the impact of whole dairy matrix on
muscle and bone, specifically focusing on fermented dairy
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products and musculoskeletal health and aging, and to identify
research gaps.
Musculoskeletal health and the aging population
Currently, more than 200 million people worldwide suffer
from osteoporosis, and with an increasingly aging population,
this number is expected to increase by approximately 30% in
the nearer future. According to the International Osteoporosis
Foundation, in the year 2000, osteoporosis was estimated to
cause more than 8.9 million new fractures globally, with 1.6
and 1.7 million being hip and forearm fractures, respectively,
and 1.4 million being clinical vertebra fractures, making oste-
oporosis considered a serious health problem. Nearly one in
two women and one in five men older than 50 years will
experience at least one osteoporotic fracture during the latter
half of their life. Including the secular trends of the global
population, the risk of hip fractures are projected to increase
dramatically by the year 2050 [9, 10].
The incidence of hip fractures is associated with increased
mortality and represents a tremendous burden on healthcare fi-
nances. With sound justification, the US National Osteoporosis
Foundation has rated calcium and dairywith the highest evidence
grade in their class as important modifiable lifestyle factors
influencing the development of peak bone mass (PBM) [11].
Sarcopenia, an age-related progressive loss of muscle mass
and function, is, like osteoporosis, a major clinical problem
among the elderly population. In Europe, low muscle strength
is the primary indicator [12]. Among Western populations,
approximately 19% to 20% of otherwise healthy men and
women above the age of 60 years suffer from sarcopenia
[13]. The consequences of sarcopenia are many and severe,
e.g., reduced muscle strength increases the risk of falls causing
bone fractures leading to decreased mobility, disability, and a
reduced quality of life. A more recently acknowledged conse-
quence is the increased risk of metabolic disorders, as type 2
diabetes is caused both due to low physical activity levels and
reduced muscle mass in the elderly [14]. Increased dietary
intake of protein, preferably in combination with physical ac-
tivity or exercise, has been proven effective to augment the
gains in muscle mass and strength [15]. Furthermore, studies
have shown a higher anabolic stimuli of muscle protein syn-
thesis, following ingestion of dairy over plant-based proteins
[16–18].
The following sections in the present paper will describe
the scientific evidence on the effect of dairy products and its
matrix in relation to musculoskeletal health.
The concept of food matrix compared to single
nutrients—the case for cardiovascular disease
Dairy is a major source of saturated fat. Previous meta-analy-
ses, on which several dietary guidelines are based, have
identified SFA to be associated with increased risk of cardio-
vascular disease [19]. Arguing that high plasma low density
lipoprotein (LDL) cholesterol is a key risk factor for coronary
artery disease [19, 20], the European Food Safety Authority
advocates not only keeping dietary intake of saturated fatty
acids below 10% of energy intake but to keep it as low as
possible [21]. In the current US dietary guidelines, the advice
is to consume “Fat-free or low-fat dairy, including milk, yo-
ghurt, cheese,” i.e., to avoid or at least reduce SFA intake.
Current Nordic Nutrition Recommendations and American
Heart Association guidelines advise a shift from whole fat to
low fat dairy products [1, 2, 22].
Recent research has shown that SFAs, as a group, do not
exert the adverse effect on CVD as previously believed, and
that the various SFA exert very different biological effects,
and that health effects are substantially modified by the food
matrix [23–25]. One example is cheese, which might be ex-
pected to increase CVD risk due to its high content of SFA and
sodium, but studies indicate the opposite, with a reduction in
blood pressure, and reduced risk of CVD and particularly of
stroke with increased cheese consumption [26–28]. Similarly,
an updated meta-analysis including 29 cohort studies found
inverse associations between total intake of fermented milk
products, including soured products, yoghurt, and cheese [29].
Moreover, dairy consumption during energy intake restric-
tion is among 12 RCTs associated with a reduction in fat mass
by 1.11 kg (95% CI −1.75 to −0.47, P = 0.001) and increased
body lean mass by 0.72 kg (95% CI 0.12 to 1.32, P = 0.02)
[30].
The effect of a given nutrient may vary dramatically de-
pending on the composition, which may account for the ob-
served different effects of dairy products, whether fermented
or not. Some of these differences may have consequences for
dietary guidelines for local populations, for harmonizing
guidelines across countries, and for the health maintenance/
disease prevention outcomes of the guidelines.
Maintaining the general advice to reduce total SFA will
work against the intentions of dietary advice, and weaken
the impact of dietary guidelines on chronic disease incidence
and mortality. A food-based translation of the recommenda-
tions for SFA intake would avoid unnecessary reduction or
exclusion of foods that may have important health benefits
[5]. Provided the current scientific knowledge, there are no
unfortunate consequences for consuming dairy, especially
fermented, as part of a healthy and varied diet.
The dairy food matrix and plant-based alternatives
in relation to bone and skeletal muscle health
Dairy products represent one of the five core food groups
embedded in most dietary guidelines worldwide. Recent up-
dates of dietary guidelines in the USA and Australia [2] have
included plant-based alternatives, especially soy-based
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products, to the dairy food group, to accommodate those who
may do not consume dairy foods such as vegans or those with
lactose intolerance. These are often presented as suitable al-
ternatives to milk, though nutritionally their content may not
compare at all, especially for products essentially devoid of
protein (Table 1). The small number of prospective studies
and RCTs comparing dairy products with plant-based alterna-
tives indicate that dairy appears more beneficial for bone
health [31, 32].
Milk drink or plant-based beverage?
In the EU, with the exception of coconut, only beverages
produced by the mammary glands are permitted to use the
term “milk” in their description when marketed in the EU,
and only when obtained from one or more milkings without
either addition thereto or extraction therefrom [33]. “Dairy
products” refers to products derived exclusively from milk,
e.g., whey, cream, butter, buttermilk, cheese, and yoghurt.
The names or descriptions of products of plant origin are, by
legislation, not allowed to contain the words milk, cheese, or
yoghurt. Nonetheless, several manufacturers of plant-based
alternatives use “milk” when describing their product.
Dairy milk has a higher protein content than the majority of
its plant-based alternatives, which stimulates the synthesis of
growth factors like IGF-I and promotes bone formation
(Table 1) [35, 36]. Soy-based drinks have similar levels of
protein as milk, but animal sources of protein tend to be more
easily digested, and the distribution of the nine essential amino
acids is considered to be better aligned with human require-
ments, particularly for muscle and bone formation [37].
Bone is a dynamically changing structure, with mineral
deposition beginning in utero, and with bone mineral content
(BMC) increasing 40-fold from birth until the end of the sec-
ond decade of adult life, when PBM is achieved. Factors
within the dairy matrix other than protein and calcium content
may play an important role in the effect of dairy on growth. At
12 weeks postnatal, infants receiving a high sn-2 palmitate
formula (i.e., mimicking the sn-2 palmitate content of human
milk) since birth had significantly greater absorption of fat and
calcium, and higher bone strength compared to infants receiv-
ing a regular formula with low sn-2 palmitate [38].
Approximately 40% to 60% of adult bone mass accrues dur-
ing adolescence and milk intake during childhood and adoles-
cence has been associated with higher BMC, with consump-
tion of more than three servings of milk per day associated
with a greater adult height in girls compared to those drinking
less than one serving per day [31]. For each cup of plant-based
drink relative to milk, children were 0.4 cm (95% CI 0.2–0.8
cm) shorter. Though not fully understood, the increasing effect
of dairy on height growth among children and adolescents
may be due to a combining effect of IGF-I, growth hormone,
and the milk proteins whey and casein [39].
An RCT in 141 postmenopausal women found consump-
tion of milk superior in preventing BMD loss at the hip and
femoral neck over an 18-month period compared to soy drink
[32]. Although the calcium intake was similar in both groups,
the observed skeletal differences were attributed to a poten-
tially higher bioavailability of calcium from milk.
Bioavailability
Calcium bioavailability in plant sources varies consider-
ably, partially due to the presence of absorption inhibitors such
as oxalates and phytates. In addition to calcium, milk also has
a high concentration of other micronutrients, such as phospho-
rus, magnesium, potassium, and vitamin A, which are impor-
tant for bone health. It also serves as a good substrate for
fortification with vitamin D (i.e., fat-soluble vitamin) due to
milk’s fat content.
Table 1 The nutritional profile of cow’s milk and plant-based alternatives, with and without fortification (nutritional content per 100 mL of beverage)
Milk Soy drink Soy drink, fortified Almond drink Rice drink Rice drink, fortified Oat drink Oat drink, fortified
Energy, kcal 64 55 45 47 50 54 50 45
Energy, kJ 268 230 188 197 209 226 209 188
Protein, g 3.4 3.1 3.3 0.7 0.1 0.1 0.6 0.5
Total lipid, g 3.5 2.3 1.9 2.2 0.9 0.9 1 1.6
Carbohydrate, g 4.9 5.3 3.6 5.9 10.3 11.4 9.7 7.2
Vitamin A, RE 35.3 0 0 0 0 0 0.34 0
Vitamin B2, mg 0.18 0.01 0.02 0.02 0 0 0.01 0.01
Vitamin B12, μg 0.39 0 NA NA NA NA NA NA
Calcium, mg 119.0 9.86 74.5 8.8 1.85 84.3 6.56 126.0
Zinc, mg 0.36 0.25 0.28 0.11 0.03 0.05 0.41 0.08
Iron, mg 0.02 0.45 0.50 0.12 0.01 0.23 0.03 0.44
Iodine, μg 16.5 1.3 9.35 0.89 1.04 2.5 0.418 5.9
Phosphorus, mg 91.0 44.1 41.5 14.3 7.39 28.0 13.2 16.9
Data from the Danish National Food Institute [34]
RE retinol equivalents, NA not assessed
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Calcium bioavailability is determined by both its chemical
structure and by interrelation with other nutrients in the diet,
e.g., phosphorus. A limited number of papers have assessed
the bioavailability of calcium in milk versus soy beverage.
Available data indicate that bioavailability in soy drink is de-
pendent on the chemical structure of the added calcium.
Tricalcium phosphate is not as bioavailable as the calcium in
cow’s milk [40], while the bioavailability of calcium carbon-
ate is in some studies found similar to that of calcium in cow’s
milk while in others found to have a less positive effect on
bone formation [41–43]. However, the specific type of calci-
um is most often not specified in the list of ingredients on
fortified plant-based beverages, making it difficult for the con-
sumer to make an informed choice. Given the potentially large
impact of dairy calcium, we call for high-quality studies in-
vestigating the effect of different dairy matrices on musculo-
skeletal health.
The calcium-to-phosphorus ratio (Ca:P) in foods is a deter-
mining factor for mineral absorption and for the formation of
structural bone matrix [42]. To meet the requirements at the
different stages of growth, the recommended range of Ca:P
intake ratio is 1:1 and 2:1 in adults and children, respectively
[44]. The ratio (w/w) of Ca:P in cow’s milk is 1.3:1, whereas it
is 0.2:1 in unfortified and 1.8:1 in fortified soy drink.
However, the bioavailability of the type of calcium used for
fortification of plant-based alternatives may result in a much
lower absorption ratio. Both phytate and oxalic acid, present
in cereals, bran, soybean, and nuts, bind with calcium and
reduce calcium absorption dose dependently [45]. Moreover,
the high content of oxalate in the plant-based beverages, in
particular almond drink, has led to concern of risk of
hyperoxaluria and genitourinary disorders in children
ingesting these drinks on a daily basis [46].
Little is known about the bioavailability of other minerals,
vitamins, and trace elements in plant-based alternatives to
milk.More research is needed to fully understand the bioavail-
ability of nutrients in different foods, the possible effects of
one food on the bioavailability of nutrients from other foods
ingested at the same time, and the potential interaction of
nutrients used for the fortification of plant-based alternatives
that might affect nutrient bioavailability.
Fermented dairy products are reported to be more potent
than other milk products in increasing absorption of nutrients
[47]. This is likely due to their pre- and pro-biotic content and
their beneficial effect of gut microflora, calciotrophic and
growth hormones, and intestinal inflammation, which conse-
quently lead to inhibition of bone resorption and stimulation
of bone formation. Fermentation of calcium-fortified soy drink,
on the other hand, does not improve acute calcium absorption in
women with subnormal or normal vitamin D status [8, 47–49].
However, bioavailability is irrelevant if the nutrient stated
to be present in the drink does not actually reach the consumer.
A simple assessment of how much calcium is present in a
glass of fortified soy drink showed that the calcium content
was just 31% of the declared content when poured unshaken,
and shaking only resulted in an improvement to 59% of the
declared content. Indeed, one sample failed to reach 20% of
declared calcium content when shaken [50].
Dairy is also a major source of vitamin B12, important for
the nervous system, cognitive function, and blood cell health,
while plant-based alternatives do not contain vitamin B12 and
are not fortified with it (Table 1). Deficiency of vitamin B12
can take several years to develop and is difficult to measure, as
both serum and plasma stores are maintained for some time by
compensatory release of vitamin B12 from tissue. Low levels
would represent long-term deficiency. Substitution of plant-
based drinks for milk without alternative sources of vitamin
B12 in the diet may not only compromise skeletal and muscle
growth but may also have detrimental effects on the nervous
system and blood cells.
Based on the content of nutrients, there is little evidence to
indicate that plant-based alternatives would exert the same
beneficial effects as dairy products on bone, but to our knowl-
edge, there are no intervention studies assessing the effect of
plant-based alternatives on bone. Therefore, to evaluate the
effect of exchanging plant-based alternatives for milk, high-
quality RCTs and/or prospective studies are needed.
The role of nutrients and the food matrix on growth
and bone health in children and adolescence:
consequences for later life
During development from infancy to adulthood, bones grow
in length, width, and density at varying rates, until reaching
PBM in early adulthood. Bone mass declines gradually there-
after, the rate of decline increasing significantly in women at
menopause before achieving a new level, after which it de-
clines gradually. It is generally accepted that PBM is one of
the main predictors of later fracture risk in adulthood and old
age [51]. Depending on the skeletal site, PBM is typically
reached at age 20 to 30 years. Bone growth and mineralization
during infancy, childhood, and adolescence are important for
optimizing PBM and may influence the risk of osteoporosis in
later life. A 10% increase in PBM in females could theoreti-
cally be estimated to delay the onset of postmenopausal oste-
oporosis by up to 13 years [52]. Total bone mass is influenced
by bone size, length, width, and density, i.e., the accrual of
minerals within the bone.
In mammals, including humans, intake of milk occurs dur-
ing periods of high growth rates, especially early in life. All
mammals feed on milk from birth through early infancy, and
in some species, this continues for several years when growth
rate is high. In humans, after weaning, many children continue
to consume milk and other dairy products (mainly bovine),
and in populations that are lactose tolerant, it is common to
continue consumption throughout life.
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Several nutrients play a role in bone health during growth;
those with an expected positive influence include calcium,
vitamin D, vitamin K, and high-quality protein. Milk and
dairy products are rich in calcium and high-quality protein,
and also contain many other minerals, and almost all vitamins
and factors stimulating growth [53]. In 1998, Bogin presented
the “milk hypothesis”: a prediction that a greater consumption
of milk during infancy and childhood would result in taller
stature later in life [54, 55]. Bogin implies that there is a
“height factor” in dairy, which is likely to be a nutrient, or a
combination of nutrients. This is supported by observational
studies reporting associations between milk intake and linear
growth among well-nourished populations [56], suggesting
that milk has a growth-stimulating effect even when nutrient
intake is adequate. The strongest evidence that cow’s milk
stimulates linear growth comes from observational and inter-
vention studies in low-income countries. A meta-analysis of
intervention studies found that 245 mL milk supplementation
daily resulted in 0.4 cm extra growth per year in children in
both developed and developing countries. The effect of milk
consumption on linear growth was higher in children with
lower height-for-age and who were peripubertal [57].
However, an effect of milk and milk-product consumption
on linear growth was not replicated in a more recent meta-
analysis including RCTs. This meta-analysis indicated that
children and adolescents consuming dairy products were more
likely to achieve a lean body phenotype due to greater increase
in lean body mass (0.21 kg; 95% CI 0.01, 0.41 kg; P < 0.05)
and simultaneously reduction in percentage fat mass (−0.27%;
95% CI −0.45%, −0.09%; P < 0.01) compared to controls
[58]. This is supported by another meta-analysis including
12 studies in adolescents, where dairy intake was inversely
associated with adiposity (average effect size −0.26 (−0.38,
−0.14) P < 0.0001) [59]. Though a lower risk of adiposity is
associated with milk intake in adolescence, some studies find
links between adiposity in childhood (age 7 years) and a high
intake of milk protein in infancy and early childhood (below
age 2 years) [60]. In Denmark, this has given rise to the rec-
ommendation that bovine milk should first be introduced
when the infant is 1 year old.
Observational and intervention studies have examined the
relationship between individual nutrients or milk (products),
growth, and bone development. One of the proposed mecha-
nisms behind the effects may be stimulation of growth factors
such as IGF-I and insulin by elements in milk not present in
other animal sources, e.g., meat. Hoppe and colleagues ob-
served that consumption of 1.5 L skimmed milk daily in 24
8-year-old boys for 1 week increased serum IGF-I by 19% (P
= 0.001), s-IGF-I/s-IGFBP-3 by 13% (P < 0.0001), and insu-
lin doubled from 22.4 ± 6.6 to 45.0 ± 25.8 pmol/L (P < 0.01).
They reported no effect of an equivalent protein intake from
meat (250 g low fat meat/day) [39, 61]. In a subsequent study,
the same research group found that casein increased IGF-I
more than whey, and whey increased insulin more than casein,
when both proteins were provided in amounts equivalent to
1.5 L skimmed milk [62]. These results suggest a cumulative
effect of whey and casein on hormones important for growth,
perhaps influenced by other elements in dairy products, and
that consuming the complete product is required to maximize
its effect.
Optimal bone mineralization may also be important for
bone health and fracture risk in children, both with and with-
out disease. In 100 girls 3–15 years old with recent fractured
forearm, bone density as the total body, ultradistal radius, 33%
radius, lumbar spine, and hip trochanter was lower, and they
were more likely to have osteopenia than age-matched girls
with no fractures [63]. The 11–15-year-old girls with fractures
reported a lower intake of dairy products at ages 6–10 years
than controls, as did the 3–7-year-old girls at the time of frac-
ture. Follow-up after 4 years indicated that a previous fracture,
low total body BMD, low spine BMD, and high body weight
were risk factors for fractures [64].
Evidence from several observational and prospective stud-
ies suggests that a high consumption of dairy products, espe-
cially milk, cheese, and yoghurt, is synonymous with better
bone health. Intervention studies have subsequently investi-
gated the effect of dairy supplementation on bone health dur-
ing several stages of life. A systematic literature review of
controlled trials assessing the effect of dairy product consump-
tion on height and BMC in children concluded that
supplementing the usual diet with dairy products increases
BMC, especially in cases where the diet is poor in nutrients
due to a high intake of fast foods [65]. Thus, bone minerali-
zation appears to benefit from increased intake of dairy prod-
ucts, possibly mainly in children with a low baseline intake of
calcium [66], although many of these studies providing the
evidence are relatively short term (0.5 to 2 years). In this
regards, more long-term studies are needed to evaluate wheth-
er increasing milk intake has long-term positive consequences
for bone health and reduced fracture rates.
Dietary guidelines in several countries recommend milk
intake during childhood, but there is no universal agreement
on the optimal amount and if specific recommendations are
required based on gender and age.
Impact of dairy matrix on bone health and fracture
risk—epidemiological evidence
A meta-analysis of observational studies reported that cheese
intake was associated with reduced risk of CVD [29, 67].
Randomised controlled studies have demonstrated improve-
ments in bone mineral density and bone metabolism with
dairy food supplementation [68–70]. Especially cheese, with
a 6-fold higher calcium content than other dairy products, is
shown to increase cortical thickness of the tibia and total min-
eral density among 195 girls [67]. However, no RCT (possibly
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due to shortness of study length) has yet found the risk of bone
fracture to be reduced by dairy food supplementation.
A recent meta-analysis of observational studies of vegan/
vegetarian diets on bone health reported that a diet free of
dairy products was associated with lower BMD at the femoral
neck and lumbar spine and higher incidence of fractures in
adults [71]. Two case–control studies including infants (10–
20 months old), children, adolescents, and young adults (up to
20 years) found impaired bone strength and higher fracture
risk among those not consuming dairy products [72, 73].
However, evidence for a positive association between
dairy food consumption and fracture risk reduction is
inconsistent, possibly due to methodological differences
in study design [74, 75]. Issues include lack of consis-
tency in which dairy foods are included in analyses, number,
timing, and quality of dietary assessments, and validation of
fractures.
More recent prospective studies have been designed spe-
cifically for bone related outcomes, so anti-fracture efficacy, if
demonstrated, can be supported by mechanistic changes to
bone. This is the case with an intervention finding consump-
tion of calcium and vitamin D3-fortified dairy products for 12
months in 101 postmenopausal women decreased serum
osteocalcin and PTH concentrations, and increased IGF-I; all
indicators of reduced bone breakdown. This was confirmed by
higher BMD observed in the fortified dairy product group at
all investigated sites compared to those provided calcium sup-
plements only, and control [76].
Comparing rates of fracture risk to dietary intake of calci-
um is inconclusive. Dietary calcium intake is high in
Scandinavia, but these countries also report some of the
highest rates of fracture, while very low risks of fracture is
observed in Croatia with an equally high dietary calcium in-
take, and South American countries where calcium intakes are
low [77, 78].
Epidemiological studies investigating the association of
dairy intake with musculoskeletal health assess dietary habits
in various ways. We need to consider how well the collected
data reflect actual intake, and whether the data collection is
appropriate for relating intake of dairy to a specific health
outcome (Fig. 1).
Identifying habitual diet intake is problematic, in that die-
tary patterns change over time and it may be necessary to
collect data at multiple time points to capture a good represen-
tation of habitual diet. Moreover, difficulties arise in defining
habitual intake. The British National Diet and Nutrition
Survey reported differences between genders in general die-
tary intake, and throughout the lifespan, where, in relation to
dairy intake, females especially during adolescence reported a
reduction in dairy (mainly milk) intake [79]. In the Danish
National Diet and Nutrition Survey, the differences in nutrient
intake, though not as large, are still present [80]. This may
contribute to why results from observational studies using
different time points of dietary assessment have inconsistent
results [74, 81].
Another question is, at which life stages the greatest bene-
fits of dairy consumption on bone is exerted? When measur-
ing bone strength and fracture risk among the elderly, it may
not be relevant to record dietary intake 5 years retrospectively
while PBM, a major determinant of fracture risk in later life,
occurred during adolescence or early adulthood. On the other
hand, bone mass continues to remodel by resorption and for-
mation throughout life, making it possible to slow the natural
reduction in BMC, but there is a lack of studies reporting on
this effect.
Foods classified as dairy in analyses of dairy intake differ
between studies and countries, making it difficult to compare
data. For example, the British National Diet and Nutrition
Survey includes desserts, even some of which do not contain
dairy, when summing dairy intake, while this is not the case in
Denmark [79, 80]. Definitions in observational studies lack
consistency, where for example cream and ice cream are often
included but may be processed to such a degree that the prod-
uct is no longer comparable to other dairy products, yet is still
included [81]. Meta-analyses of observational studies poten-
tially carry the risk of bias due to the assumption of serving
sizes being equal, though they also differ substantially be-
tween countries [56]. This is the case in a newly published
meta-analysis where the effects of cheese and yoghurt con-
sumption from a Swedish and a US population are included in
the same analyses, although consumption of cheese is twice as
high and yoghurt is more than 40 times higher in the Swedish
compared to the US population [74, 75, 81]. The same obser-
vational study reports increased fracture risk and a 2% in-
creased mortality with a higher milk intake, but fails to draw
attention to a reduction of 10% in risk of fracture with in-
creased cheese and fermented dairy intake [75]. These incon-
sistencies underline the challenges in interpreting data from
epidemiological studies and that the different types of dairy
exert effects that may not be directly comparable.
Protein quality and dairy matrix effects on skeletal
muscle
Skeletal muscle tissue exerts force onto ligaments and bones
to allow functional capacity and personal autonomy. Over the
last decade, more and more information has been generated on
the existence of muscle–bone cross-talk. Mechanical loading
is the key mechanism that links both tissues, with cross-talk
being made possible by the production and release of growth
factors and myokines from skeletal muscle fibers and
osteokines secreted by osteoblasts and osteocytes [82]. Bone
and muscle health affect each other through the secretion of
myokines such as myostatin, irisin, interleukin (IL)-6, IL-7,
IL-15, IGF-1, fibroblast growth factor (FGF)-2, and β-
aminoisobutyric acid and through bone-derived factors
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including FGF23, prostaglandin E2, transforming growth fac-
tor β, osteocalcin, and sclerostin [83]. This tissue cross-talk
ensures proper alignment between tissue remodeling and, as
such, represents a key factor in maintaining bone and muscle
health. In line, common pathways are likely responsible for
the loss of bone and muscle mass in with aging in both health
and disease [84].
To maintain skeletal muscle mass and quality, muscle pro-
tein is constantly being synthesized and broken down, with a
turnover rate of about 1–2% per day. The rate of skeletal
muscle protein synthesis is regulated by two main anabolic
stimuli, food intake and physical activity. Food intake, and
more specific protein ingestion, can directly elevate muscle
protein synthesis rates by increasing the level of circulating
amino acids, with leucine being of particular relevance. The
post-prandial rise in muscle protein synthesis rate is regulated
on various levels from protein digestion, amino acid absorp-
tion, plasma amino acid availability, hormonal response, post-
prandial perfusion, amino acid–induced anabolic signaling,
and myofibrillar protein synthesis. Ingestion of a meal-like
amount of dietary protein (~20 g) elevates muscle protein
synthesis rates for several hours following ingestion, resulting
in net muscle protein accretion [85]. A substantial part of the
ingested protein-derived amino acids are taken up and directly
used to support the post-prandial rise in muscle protein syn-
thesis rate following ingestion of a single bolus of protein. The
dietary protein-derived amino acids present as strong signal-
ing molecules and act as direct precursors for de novo muscle
protein synthesis [86]. In short, ingestion of a single meal-like
amount of protein allows ~55% of the protein-derived amino
acids to become available in circulation, thereby improving
whole-body protein balance. Approximately 20% of the
protein-derived plasma amino acids will be incorporated in
de novo synthesized skeletal muscle tissue during a 5-h
post-prandial period [86], thereby stimulating muscle protein
synthesis rates and providing precursors for de novo muscle
protein. Post-prandial protein handling and the post-prandial
muscle protein synthetic response to protein ingestion are
modulated by numerous variables, including the amount,
type, and amino acid composition of the protein ingested, as
well as the matrix of the food in which the protein is provided.
Ingestion of casein hydrolysate, compared to intact casein, has
been shown to accelerate amino acid digestion and absorption
from the gut with 27 ± 6%more dietary derived phenylalanine
appearing in the circulation, which tended to further increase
post-prandial muscle protein synthesis rates [87]. Ingestion of
whey results in a greater post-prandial rise in muscle protein
synthesis rate when compared to the ingestion of intact or
hydrolyzed casein, which may be attributed to the rapid diges-
tion and high leucine content of whey protein [88]. Ingestion
of beef results in a lower availability of phenylalanine than
ingestion ofmilk during the early postprandial phase, but there
were no significant differences in myofibrillar protein synthe-
sis rate throughout a 5-h postprandial period [89]. No effect of
the co-ingestion of carbohydrate with protein on post-prandial
muscle protein synthesis has been observed [90, 91]. Co-
ingestion of milk fat with milk protein seems to delay the early
release of dietary protein–derived phenylalanine, but this does
not impair postprandial muscle protein synthesis rates [92].
A recent paper summarized the skeletal muscle protein
synthetic response to the ingestion of plant- compared to
animal-based protein consumption [93]. The review conclud-
ed that most studies indicate that plant-based protein sources
do not have the same capacity to stimulate muscle protein
synthesis upon ingestion when compared to the ingestion of
animal-based proteins. This has been attributed to the relative
low essential amino acid content, relative low leucine content,
and shortage of specific amino acids such as lysine and me-
thionine in plant-based proteins. However, only few plant-
based proteins, such as soy and wheat, have actually been
assessed for their in vivo anabolic properties. To compensate
for the lesser anabolic response to plant-based protein feeding,
more protein can be ingested. However, an increased intake of
plant-based protein may increase the risk of the diet becoming
less varied and will lower the intake of other essential nutrients
or consuming more energy than needed, with the potential for
accretion of fat mass as a consequence. Another strategy to
compensate for the lower anabolic response to plant-based
Fig. 1 Dairy matrix, more than
the sum of its nutrients. Ca,
calcium; MFG, milk fat globule;
MFGM, milk fat globule
membrane; P, phosphate; SCFA,
short-chain fatty acids; UHT,
ultra-high temperature processing
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protein ingestion is fortification of plant-based proteins with
specific amino acids. For example, co-ingestion of leucine has
been shown to further increase postprandial muscle protein
synthesis rates [94]. Addition of specific amino acids to veg-
etable protein sources may improve their otherwise subopti-
mal amino acid profile, increasing the anabolic effect.
Another, more practical strategy would be the consumption
of blends of different plant-based proteins, where some pro-
teins low in a certain amino acid will compensate for other
proteins low in other amino acids. The latter directly refers to
the general dietary recommendation to consume a diet with a
large variety of grains, legumes, and nuts. This further under-
lines the relevance of the consumption of different foods in
meals providing the required nutrients derived from different
sources.
Furthermore, non-food factors such as food prepara-
tion, mastication, body position, habitual protein intake,
physical activity, and body composition are all factors
that can influence post-prandial protein handling.
Physical activity plays a large role in increasing sensi-
tivity for up to 48 hours post-exercise, and inactivity, even
short term, induces anabolic resistance and causes rapid mus-
cle loss [95].
A simple recommendation to optimize the post-prandial
stimulation of muscle protein synthesis in a healthy popula-
tion is to consume at least three main meals, each providing
20 g of high-quality protein, spread throughout the day and the
consumption of a protein-rich snack in the evening prior to
sleep. A physically active lifestyle is required to ensure that
skeletal muscle tissue remains sensitive to the anabolic
properties of protein ingestion. Anabolic sensitivity is
required to maintain skeletal muscle mass and strength
and, as such, to preserve functional performance and
autonomy. The latter are key to the muscle–bone unit,
where constant cross-talk via growth factors, myokines,
and osteokines lies at the basis of maintaining both bone and
muscle health.
Nutrition from a holistic point of view: we eat food
not nutrients
We do not eat nutrients, we eat food. We eat foods in dishes,
we eat these dishes as meals, and these meals are part of
dietary patterns, which may determine the overall health ef-
fects of what is ingested.
Historically, investigations have focused on single nu-
trients and the effects they exert on a single signal,
molecule, or even single nucleotide polymorphisms.
Findings have then been translated into nutritional ad-
vice. This has been useful in avoiding and treating de-
ficiencies, but the approach has severe limitations in the
development or prevention of non-communicable dis-
eases globally.
Foods are more than the sum of the nutrients they contain.
Effects differ according to their physio-chemical structure—
the matrix—of the food. This is true for all the foods due to
their complexity, but also to their specific composition and
nutritional environment (for example, the diversity of dairy
fatty acids), to the presence of “minor” micro-constituents
which can play a major role, or as a consequence of
processing.
The influence of different nutrients on biomarkers of dis-
ease risk has been investigated in both observational and in-
terventional studies (Table 2). Effects may differ depending on
the form or presence of other nutrients. This is the case for
isolated fibers compared to the whole grains which contain,
for instance, lignans or arabinoxylans [96]; for carbohydrates
such as fructose whose effects differ if consumed alone or as
part of a fruit [97]; for oleic acid where effects differ for olive
oil or from fatty pork [112]; for calcium in spinach or in milk
[113]; for saturated fatty acids in meat or in cheese, which are
Table 3 Research gaps, recommendations, and future strategies
Research gaps
To what extent do dietary habits early in life influence later risk of
fractures?
Increasingly interesting due to poor dietary habits, low intake of
micronutrients among adolescents in combination with low level of
physical activity (e.g., 20–30% of UK young females have intakes of
magnesium and calcium below the recommended minimum level of
intake)
Quality of foods or its ingredients should refer to their capacity to serve a
specific function or provide specific health benefits. More in vivo
human studies are needed to assess food quality. Recommendations
More randomized controlled studies, with a solid methodological
approach, to investigate the effect of plant-based foods and beverages
are needed.
When evaluating quality of foods, the goal must be kept in mind. What
effect/quality of a product do we wish for or desire?
To show the metabolic effects of new products takes longer time than the
product development; therefore, we need to evaluate the effect of new
products on bone and muscle metabolism with attention to detail and
caution.
Pitfalls when interpreting data and comparing results; differences in
methodology and simple things as serving sizes, groups of foods,
content varies from country to country and between studies.
Future strategies
Anabolic effects of protein; we need both leucine and other amino acids in
sufficient amounts.
Can leucine supplementation increase the anabolic effect in people with
low intake and increased needs, e.g., elderly and ill or in people with no
or minimal intake of animal-based protein, i.e., vegan and vegetarian?
Future studies should investigate the effect of early dietary habits on later
risk of fractures by including long-term and family studies.
Studies investigating the digestion and absorption of different protein
sources in children, adolescents, adults, and the old; also during
specific life phases where higher nutritional demands may exist.
Standardization of study methods and dietary assessment to make results
more comparable and the outcome of meta-analyses relevant.
Public dissemination of the differences in nutritional profile mean that
plant-based beverages are not comparable with dairy products and
should not be portrayed as such.
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associated with opposite effects on cardiovascular risk in ep-
idemiological studies [5]; and for calcium, where dairy prod-
ucts showed higher effect on bone mass and weight loss than
calcium supplements [43, 67, 111]. The huge variability of
nutrients within foods, and variability due to the food they
are in and the meal it is a part of, and the possibility of vari-
ations in effect from consumer to consumer need to be ac-
knowledged and explored.
Wrapping up the workshop
The research gaps, recommendations, and future strategies
identified during the workshop are presented in Table 3. Diet
is changing rapidly, including increasing intake of new plant-
based products motivated by environmental considerations, in-
creased intake of carbonated energy drinks, and decreasing
physical activity, e.g., the use of motorized means of transpor-
tation. These lifestyle changes may have a detrimental effect on
PBM and muscle development, during growth, leading even-
tually to increased risk of bone fractures, diabetes, and obesity.
The average age of the population globally is increasing,
and an older population needs a more nutritionally dense diet.
Meeting increasing demands—both for foods and for
nutrients—raises sustainability issues. Increasing the amount
of plant-based foods in our diet is perhaps inevitably a conse-
quence, but the nutritional sufficiency and effects on health of
plant-based alternatives to animal-derived foods need to be
investigated relative to the effect of the nutrients such as pro-
tein and calcium predominantly obtained from these animal-
based foods.
In conclusion, available evidence suggests that calcium
from dairy products, in particular from fermented dairy and
cheese, exerts positive effects on bone turnover, beyond those
to be expected on the basis of the calcium content itself, with
no adverse effects on cardiometabolic health. There is a great-
er array of food matrixes, also in foods other than dairy, than
previously observed. Diet is complex and is more than simply
the sum of its nutrients. The matrix effect may, to some extent,
explain the discrepancy between observational data and data
from RCTs. We must revisit the methodology and interpreta-
tion of epidemiological studies, and a holistic approach is
essential. We must recognize the possibility of matrix effects
from all foods and include this in the design of future studies.
We propose a new dietary approach to investigate health ben-
efits of foods, beyond just nutrients, and to consider foods as
opposed to nutrients when defining guidelines on dietary
intake.
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